Determinants of Secondary Hyperparathyroidism 1 Year After One-Anastomosis Gastric Bypass or Sleeve Gastrectomy

Obes Surg. 2023 Jan;33(1):156-163. doi: 10.1007/s11695-022-06337-w. Epub 2022 Nov 1.

Abstract

Purpose: Bariatric surgery alters the anatomic and physiological structure of the gastrointestinal tract, predisposing patients to the malabsorption of nutrients. The purpose of this study was to determine the prevalence and determinants of secondary hyperparathyroidism (SHPT) in the patients undergoing either one-anastomosis gastric bypass (OAGB) or sleeve gastrectomy (SG).

Materials and methods: A total of 517 patients (without SHPT at the baseline) who had undergone OAGB or SG were prospectively assessed 1 year after the surgery. Anthropometric parameters, calcium, intact parathyroid hormone (iPTH), and 25(OH)D levels were compared according to the surgery type before and 1 year after surgery. Multiple logistic regression models were used to evaluate possible SHPT predictors after bariatric surgery.

Results: The overall prevalence of SHPT was 12.6% after surgery, significantly different between the OAGB and SG groups (17.1 vs. 9.9%, respectively). The serum levels of albumin-corrected calcium and 25(OH)D were not significantly different between the two groups. The patients undergoing OAGB had significantly higher serum levels of ALP (198.2 vs. 156.6) compared to the subjects undergoing SG. Higher iPTH levels preoperatively, lower 1-year excess weight loss%, and OAGB surgery seemed to be independent predictors for SHPT 1 year after surgery.

Conclusion: Morbidly-obese patients undergoing OAGB had a higher risk of SHPT than their counterparts undergoing SG, whereas 25(OH)D deficiency and calcium levels did not differ between the two groups. The OAGB procedure, preoperative iPTH levels, and 1-year weight loss were predictors of postoperative SHPT development.

Keywords: 25-hydroxyvitamin D; One-anastomosis Gastric bypass; Parathyroid hormone; Sleeve gastrectomy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium
  • Gastrectomy / adverse effects
  • Gastrectomy / methods
  • Gastric Bypass* / adverse effects
  • Gastric Bypass* / methods
  • Humans
  • Hyperparathyroidism, Secondary* / epidemiology
  • Hyperparathyroidism, Secondary* / etiology
  • Hyperparathyroidism, Secondary* / surgery
  • Obesity, Morbid* / surgery
  • Retrospective Studies
  • Weight Loss

Substances

  • Calcium